Newborn Sequencing Screening in China

Status Not yet recruiting

Clinical Trial Summary

The project will carry out the genetic testing of 10000 neonates. The aim of the project is to assess the application of targeted sequencing technology in the screening of neonatal diseases.

Clinical Trial Description

Neonatal screening (NBS) is the last step of birth defects prevention. Currently, biochemical and mass spectrometry are commonly used for NBS, but there are limited diseases and certain false positive/negative. High-throughput sequencing (NGS) has been widely used in prenatal diagnosis, tumor-targeted biomarkers detection and pathogen detection. Although the application of NGS in new screening has a broad prospect and many countries around the world have begun to explore it, there are still challenges in the selection of screening diseases, gene clinical phenotypes, genetic counseling and clinical pathway. Since 2019, our team began to explore the appllication of NGS technologies in the clinical application of tertiary prevention, combined with Clinva, HGMD, OMIM database, on the basis of screening specific disease-causing genes and mutation sites as the target, A NGS panel for Newborns in China (NeoExome) was designed, covering 542 single-gene diseases with 601 genes. The rationality and validity of the NGS panel was preliminarily verified in 3423 neonatal blood samples collected from 5 new screening centers in China. In order to further optimize the gene screening spectrum of neonatal diseases in the Chinese population, evaluate the efficacy of targeted sequencing technology in the screening and diagnosis of neonatal diseases, standardize the clinical pathway, and lay a foundation for the formulation of China's new screening NGS guidelines, the investigators further optimized the targeted sequencing package (NeoexOME-V2) on the basis of the first phase. 491 genes covering 485 single-gene genetic diseases were designed to launch the "Budding Action". The project plans to collect 10000 samples nationwide and carry out the multi-center clinical research on the application of targeted sequencing technology in the screening of neonatal diseases. ;

Study Design

Related Conditions & MeSH terms

Newborns

Clinical Trial Details

NCT number	NCT05476640
Study type	Observational
Source	Shanghai Children's Hospital
Contact	Lin Zou
Phone	18623121280
Email	zoulin@shchildren.com.cn
Status	Not yet recruiting
Phase
Start date	August 5, 2022
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01687634` - Home Visiting for Low Income, Pregnant Women	N/A
Completed	`NCT02584166` - Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPERA)	N/A
Recruiting	`NCT04598061` - IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
Recruiting	`NCT04410250` - Effect of Oral Hygienization in Newborn on Candida Spp Colonization	N/A
Recruiting	`NCT05705258` - A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Recruiting	`NCT02785679` - The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy	N/A
Recruiting	`NCT06350071` - Effect of Kangaroo Care and Swaddling Methods on Pain Level and Crying Time During Heel Blood Collection	N/A
Terminated	`NCT03142984` - UK Baby Study Using a Baby Wash and Lotion Regimen	N/A
Completed	`NCT06387888` - The Effect of Mother's Voice on the Levels of Pain and Comfort in Newborns	N/A
Completed	`NCT02827019` - Newborn in Helathy Birthroom: Assessment of Pratical Home and Mother Lived
Recruiting	`NCT04984967` - Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology	N/A
Completed	`NCT04492579` - Newborns Supplemented With Gentle-UHT Donor Milk	N/A
Completed	`NCT03637894` - Immunity Modification of Full Term Infants According to the Type of Feeding and Mode of Delivery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.